Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.55
-10.32 (-4.43%)
AAPL  267.44
-0.02 (-0.01%)
AMD  230.29
-10.23 (-4.25%)
BAC  51.64
+0.16 (0.31%)
GOOG  284.96
-0.64 (-0.22%)
META  597.69
-4.32 (-0.72%)
MSFT  493.79
-13.70 (-2.70%)
NVDA  181.36
-5.24 (-2.81%)
ORCL  220.49
+0.63 (0.29%)
TSLA  401.25
-7.67 (-1.88%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.